Med-X: Why Investors Should Be Paying Attention

The world is changing, and so too are opinions. Today, opinions with regard to cannabis, pharmaceuticals, chemicals, and more are constantly being scrutinized. Med-X is a company that is riding on the leading edge of this change and creating a compelling opportunity in the process.

What Is Med-X

Med-X is a company that is becoming a disruptive force across multiple sectors. In particular, the company is focused on creating alternatives to poisonous chemicals often used in pest control, and re-imagining outdated pharmaceuticals. The company is also setting the foundation for the cultivation of medical grade hemp and cannabis when it becomes federally legal to do so, and is using its magazine, The Marijuana Times, to educate consumers as regulatory evolution in the space continues.

Med-X as A Cannabis Play

While there are various facets to Med-X, with so much interest in cannabis around the world, this proves to be a great growth opportunity. When it comes to the company’s involvement in the cannabis sector, Med-X is focused on three key factors; education, innovation and cultivation.


Med-X operates an online magazine known as The Marijuana Times. Through the magazine, the company’s primary goal is to educate and provide thoughtful and engaging content that is created directly for the cannabis community. The company also takes part in the development of educational content and distribution through various mobile applications and social platforms like Apple News, LinkedIn, YouTube, Apple Podcast, and other social networking outlets.


Med-X is a company that is driven by innovation, and its innovation will likely lead to disruption in various sectors. However, in the cannabis sector, the company is innovating solutions for outdated poisonous chemicals that are often used in pest control and cultivation of cannabis. Various dangerous chemicals are used in the cultivation of cannabis, including fertilizers and pest control agents. Unfortunately, cannabis cultivators are highly under–regulated when it comes to the use of chemicals. Some have been known to inject cannabis with high levels of synthetic chemicals, which could be dangerous to the consumer. With the Nature-Cide product line and methods, the company is combatting the use of these dangerous chemicals by providing safe, green alternatives.


Med-X intends to research and cultivate medical grade cannabis and hemp for testing and ancillary product development once it becomes federally legal to do so. The company is highly active in research with regard to their Nature-Cide product in the cultivation of medical grade cannabis and hemp. In late 2015 and early 2016, Med-X followed a patient group while providing Nature-Cide products for cannabis cultivation and testing. The company worked to make sure that the cannabis grown and cultivated was done so using Nature-Cide cultivation methods to ensure purity standards. Through the study, the company was able to compile a plethora of positive data that has been featured in the Nature-Cide 18-month Integrated Pest Management report.

Med-X As A Pharmaceutical Play

As mentioned above, Med-X has the potential to become a disruptive force across multiple industries. One of these industries is the pharmaceuticals industry. The company focuses on creating alternatives to various dangerous medicines.

In the pharmaceutical space, Med-X offers the Thermal-Aid and Malibu Brands lines. The Thermal-Aid line is an all-natural line of heating and cooling products. The Malibu Brands first product is a botanical topical called Pacific Pain Relief Cream. These products were designed specifically for the medical field, and have been developed by doctors. The effectiveness of these proprietary products has been clinically proven. Both of the product lines are designed to help patients across a wide array of medical indications, including but not limited to:

  • Arthritis – Inflammation in one or more joints, causing pain. This condition tends to worsen with age.
  • Fibromyalgia – A condition characterized by widespread muscle pain and tenderness.
  • Multiple Sclerosis – A debilitating disease that causes the immune system to eat away at the protective covering of nerves within the body.
  • Migraines – Headaches of varying intensity that are often accompanied by nausea and sensitivity to light and sound.
  • Back Pain – Pain and tenderness in the back.
  • Muscle Aches – Pain and tenderness in the muscles.

Today, Thermal-Aid products are available through a wide range of over-the-counter pharmacies. They also qualify for patient insurance reimbursement and FSA programs throughout the United States. The Malibu Brands line is set to launch for consumers in the first quarter of 2019.

Med-X also has a line of products known as Home Spa that have the potential to become a driving force in the aromatherapy space. The company’s Home Spa products are 100% natural shower sprays that have been developed using the highest quality ingredients. Through the use of a unique blend of natural, therapeutic and essential oils, Home Spa was developed as a way to help ease stress and clear one’s mind.

The Med-X Client Footprint Is Growing

At the moment Med-X has a national client footprint that is growing quickly. That footprint includes a network of commercial customers using the Nature-Cide brand, which include pest control customers like PestMaster Services. The company is also a supplier to distribution giants such as Univar and Target Specialty Products, which includes the parent company of Target Specialty Products, Rentokil Initial. Rentokil Initial has been placing Nature-Cide products in various regions including Hong Kong and Mumbai. The Nature-Cide line up is being used in places like hospitals, transportation venues such as buses, trains and aircraft, school districts, amusement parks and zoos, due to its low environmental impact as well its non- toxic risk factor to human and animals. Moving forward, Med-X intends to continue aggressive marketing within the worldwide Pest Control, Hospitality, Transportation, Agriculture, and Janitorial Supply markets, and is pursuing the implementation of Nature-Cide in state and federal facilities throughout the United States.

The Market Potential is Massive

Since Med-X is becoming a driving force across various high-value industries, the market potential for its products is incredible. The global insect pest control market is expected to grow to $17.3 billion by 2022, according to research firm MarketsandMarkets. At the same time, the global pain management drug market is estimated to grow to $44.3 billion by 2020. In fact, it is anticipated that the global pain management drug market will have a compound annual growth rate (CAGR) of 3.2% through 2020 according to BCC Research. Then,when including the tens of billions in revenue that the cannabis market is expected to create once it becomes federally legal, it is hard to ignore the potential brought to the table by Med-X.

The Management Team

The Med-X management team is an incredibly impressive one, featuring physicians, financial experts, marketing experts, and more. Here’s a quick look at some of the notable figures that are featured in the company’s management team:

  • Dr. David Toomey – Dr. David Toomey is the CEO and Director at Med-X. Dr. Toomey worked as a family physician for more than 24 years and as a hospice medical director for the past 10 years. Dr. Toomey is also known for his work as a clinical investigator in various clinical trials, many of which were conducted by major pharmaceutical companies.
  • Matthew A. Mills – Matthew is the President and COO of the company since its inception. Matt is often credited as being the visionary of the company and has vast experience in product development, operations, business development, manufacturing, marketing, and crowdfunding.
  • Ronald J. Tchorzewski – Mr. Tchorzewski is the CFO and Director of the company since its inception. He has vast experience in the financial accounting space for start-up and development companies as well as reporting for publicly held companies.
  • Nick Phillips – Mr. Philips is the Vice President, Editor-in-Chief, and drives The Marijuana Times digital magazine to fill a void in the reporting of the cannabis industry by providing a voice, education and news about the cannabis community. His skillset coupled with his dedication to all of the Med-X web properties and technology, along with his attention to detail gives Med-x the leading edge in the industries the company is positioned in.

The above names are just a few in the impressive management line up. To learn more about the company’s management, please visit their Start Engine page.

Investor Interest

With the disruptive products that Med-X has developed and is working to develop, it’s not surprising to see that the company is generating quite a bit of investor interest. At the moment, the company has an active Regulation A+ offering that was launched on Start Engine, and has garnered quite a bit of attention. In fact, the company has raised more than $4 million from more than 1,800 investors through the platform thus far. Moreover, throughout the year 2018, the company raised over $2 million through a Regulation 506(c) offering.

Why You May Want To Consider Med-X

Med-X is a company that is well positioned to embrace and benefit from the changing regulations and opinions surrounding the cannabis industry. The company has also done well positioning itself to become a leader in emerging alternative markets, as green technology seems to be causing a shift in the way consumers think, act, and live.

The company is quickly becoming a disruptive force in the pest control industry, is poised to cause disruption in the pain management industry, and has laid the groundwork for the cultivation of cannabis once it becomesfederally legal to do so in the United States.

Ultimately, the company is focused on laying the groundwork to become a leader in multiple areas with incredible market potential. The company is already well on its way with various products that are quickly growing in demand by consumers and professionals. The company operates on the leading edge of innovation, with an unmatched leadership team, proven products, and massive market potential. This is an opportunity that we believe is hard to ignore!

Disclaimer- CNA Finance is NOT an Investment Advisor. Our goal is to bring both news and under discovered stocks to the attention to investors to assist in making smart decisions in the market. CNA Finance is a for profit company. That profit is generated through three (3) different types of relationships. First and foremost, we work with pay per click and CPM advertisers on banners. We also have affiliate relationships with various companies where we earn a portion of the sales we refer. Finally, we may have relationships with some of the companies or IR firms that represent companies mentioned within our works in which we are compensated in cash and or stock for consulting, investor relations, and Press Release services. Med-X paid CNA Finance $6,000 for research and writing services as well as other digital investor relations tasks. Therefore, while we do everything in our power to provide true, well-researched, and well-thought out opinions, in some instances, a potential conflict of interest may exist. CNA Finance encourages all investors to seek professional advice before making any investment decision.

Leave a Comment